CD40 stimulation obviates innate sensors and drives T cell immunity in cancer

Byrne, Katelyn T., Vonderheide, Robert H.·2016·Cell Reports

DOI 10.1016/j.celrep.2016.05.058

Cited by (283)

Items 101–200 of 283

CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype toward M1 and Suppress Human Pancreatic Cancer in Organotypic Slice Cultures
Chae Yoon Lim, Jae Hyuck Chang, Won Sun Lee, Jeana Kim, Il Young Park · 2021 · Gut and Liver
Tumor-Specific CD4 T Cells Instruct Monocyte Differentiation in Pancreatic Ductal Adenocarcinoma
Michael T. Patterson, Adam L. Burrack, Yingzheng Xu, Grant H. Hickok, Zoe C. Schmiechen, Samuel Becker, Eduardo Cruz-Hinojoza, Patricia R. Schrank, Ainsley E. Kennedy, Maria M. Firulyova et al. · 2022 · Cell Reports
CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity
Suresh de Silva, George J. Fromm, Casey W. Shuptrine, Kellsey Johannes, Arpita Patel, Kyung Jin Yoo, Kaiwen Huang, Taylor Houghton Schreiber · 2019 · Cancer Immunology Research
The role of tumor heterogeneity in immune-tumor interactions
Shelby M. Knoche, Alaina C. Larson, Bailee H. Sliker, Brittany J. Poelaert, Joyce C. Solheim · 2021 · Cancer and Metastasis Reviews
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N. Khalil, Nathan Suek, Luís Felipe Campesato, Sadna Budhu, David Redmond, Robert M. Samstein, Chirag Krishna, Katherine S. Panageas, Marinela Capanu, Sean Houghton et al. · 2019 · Journal of Clinical Investigation
T-Cell Immunity in Pancreatic Cancer
Reham Ajina, Louis M. Weiner · 2020 · Pancreas
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
Alexander Muik, Homer Adams, Friederike Gieseke, Işıl Altıntaş, Kristina B. Schoedel, Jordan M. Blum, Bianca Sänger, Saskia Maria Burm, Eliana Stanganello, Dennis Verzijl et al. · 2022 · Journal for ImmunoTherapy of Cancer
Dendritic cell subsets and implications for cancer immunotherapy
Michael Y. Chen, Felicia Zhang, Simon Peter Goedegebuure, William E. Gillanders · 2024 · Frontiers in Immunology
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou‐Feige, Jackeline F. Romero, Eva Sum, Moritz Rapp, Gaël Boivin, Tania Wyss, Christian Simon et al. · 2021 · Clinical Cancer Research
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism
Honglin Jiang, Tristan Courau, Joseph Borison, Alexa J. Ritchie, Aaron T. Mayer, Matthew F. Krummel, Eric Andrew Collisson · 2021 · Gastroenterology
Intrinsic cancer vaccination
Yoosoo Yang, Gi‐Hoon Nam, Gi Beom Kim, Yoon Kyoung Kim, In‐San Kim · 2019 · Advanced Drug Delivery Reviews
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
Jonas R.M. Van Audenaerde, Elly Marcq, Bianca von Scheidt, Ashleigh S Davey, Amanda J. Oliver, Jorrit De Waele, Delphine Quatannens, Jinthe Van Loenhout, Patrick Pauwels, Geert Roeyen et al. · 2020 · Clinical & Translational Immunology
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
Karin Enell Smith, Adnan Deronic, Karin Hägerbrand, Per Norlén, Peter Ellmark · 2021 · Expert Opinion on Biological Therapy
Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Taciana Manso, Anjana Kushwaha, Nika Abdollahi, Patrice Duroux, Véronique Giudicelli, Σοφία Κοσσίδα · 2023 · Frontiers in Immunology
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma
Il‐Kyu Kim, Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Benjamin Kahn, Qinglan Li, Jeffrey H. Lin, Jinyang Li, Robert J. Norgard, Stacy K. Thomas et al. · 2024 · Nature Communications
Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma
Veethika Pandey, Peter Störz · 2019 · Expert Review of Anticancer Therapy
The dark side of immunotherapy: pancreatic cancer
Gianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, Silvia Brugiapaglia, Francesco Novelli, Paola Cappello · 2020 · Cancer Drug Resistance
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell, Lorenzo Galluzzi · 2017 · OncoImmunology
Tumor necrosis factor superfamily signaling: life and death in cancer
Obada Ehab Ababneh, Daisuke Nishizaki, Shumei Kato, Razelle Kurzrock · 2024 · Cancer and Metastasis Reviews
Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients
Max Miller Wattenberg, Veronica M. Herrera, Michael A. Giannone, Whitney Lynn Gladney, Erica L. Carpenter, Gregory Lawrence Beatty · 2021 · JCI Insight
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity
Xiang Ling, Xiaomin Jiang, Youyou Li, Wenbo Han, Megan Rodriguez, Ziwan Xu, Wenbin Lin · 2020 · ACS Nano
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Nebojša Skorupan, Mayrel Palestino Domínguez, Samuel L. Ricci, Christine Alewine · 2022 · Cancers
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Huiru Zhang, Long‐Yun Ye, Xianjun Yu, Kaizhou Jin, Weiding Wu · 2022 · Frontiers in Immunology
Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions
Ligia I. Bastea, Geou‐Yarh Liou, Veethika Pandey, Alicia K. Fleming Martinez, Christina A. Von Roemeling, Heike R. Döppler, Zhimin Li, Yushi Qiu, Brandy H. Edenfield, John Alton Copland et al. · 2019 · Cancer Research
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Aarushi Audhut Caro, Sofie Deschoemaeker, Lize Allonsius, An Coosemans, Damya Laoui · 2022 · Cancers
Combined Flt3L and CD40 agonism restores dendritic cell–driven T cell immunity in pancreatic cancer
Graham D. Hogg, Alyssa G. Weinstein, Natalie L. Kingston, Xiuting Liu, Olivia M. Dres, Liang‐I Kang, Varintra E. Lander, Yu‐Lan Kao, Faiz F. Ahmad, Brett L. Knolhoff et al. · 2025 · Science Immunology
Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2021 · Cancer Immunology Research
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2022 · Cancer Research
Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer
Katie E. Blise, Shamilene Sivagnanam, Courtney B. Betts, Konjit Betre, Nell C. Kirchberger, Benjamin J. Tate, Emma Elizabeth Furth, Andressa Dias Costa, Jonathan Andrew Nowak, Brian Matthew Wolpin et al. · 2024 · Cancer Immunology Research
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
David J. Zahavi, Louis M. Weiner · 2019 · International Journal of Molecular Sciences
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
Karin Hägerbrand, Laura A. Varas, Adnan Deronic, Barnabas Nyesiga, Anette Sundstedt, Lill Ljung, Christina Alexandra Sakellariou, Doreen Werchau, Mia Thagesson, David Gomez Jimenez et al. · 2022 · Journal for ImmunoTherapy of Cancer
Enterotoxins can support CAR T cells against solid tumors
Bianca von Scheidt, Minyu Wang, Amanda J. Oliver, Jack D. Chan, Metta K. Jana, Aesha I. Ali, Fiona Clow, John D. Fraser, Kylie M. Quinn, Phillip Kevin Darcy et al. · 2019 · Proceedings of the National Academy of Sciences
A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression
Nicolò Rigamonti, Niina Veitonmäki, Clara Domke, Sophie Barsin, Sarah Jetzer, Omar Abdelmotaleb, Ralph Bessey, Tamara Lekishvili, Francesca Malvezzi, Mariam A. Gachechiladze et al. · 2022 · Cancer Immunology Research
Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients’ response to cancer immunotherapy
Hany A. Omar, Mai Fathy Tolba · 2019 · Critical Reviews in Oncology/Hematology
Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer
Courtney T. Stump, Kevin Roehle, Nataly Manjarrez‐Orduño, Stephanie K. Dougan · 2021 · Open Biology
C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer
Kosuke Sasaki, Shigetsugu Takano, Satoshi Tomizawa, Yoji Miyahara, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Mamoru Takada, Masayuki Ohtsuka · 2021 · Journal of Experimental & Clinical Cancer Research
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Nehal J. Lakhani, Daphne B. Stewart, Debra L. Richardson, Lauren Dockery, Linda Van Le, Justin Call, Fatima A. Rangwala, Guanfang Wang, Bo Ma, Simon Metenou et al. · 2025 · Journal for ImmunoTherapy of Cancer
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
Belinda Lee, Peter Gibbs · 2019 · Journal of Personalized Medicine
High versus low dose irradiation for tumor immune reprogramming
María Ochoa de Olza, Jean Bourhis, Melita B. Irving, George Coukos, Fernanda Gabriela Herrera · 2020 · Current Opinion in Biotechnology
Immune Checkpoint Inhibitors: Recent Clinical Advances and Future Prospects
Abid Hussain Banday, Mohnad Abdalla · 2022 · Current Medicinal Chemistry
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos, Athanasios G. Papavassiliou · 2024 · Cancers
Targeting phagocytosis checkpoints for cancer immunotherapy
André Veillette, Jiaxin Li, Cristian Camilo Galindo, Dominique Davidson, Zheng-Hai Tang · 2025 · Nature reviews. Cancer
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma
Daniel H. Ahn, Ramesh K. Ramanathan, Tanios Bekaii‐Saab · 2018 · Cancers
Lipid Nanoparticle‐mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response
Riddha Das, Xinying Ge, Fan Fei, Sepideh Parvanian, Ralph Weissleder, Christopher Garris · 2024 · Small Methods
A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Robert E. Van Sciver, Michael Lee, Caroline Guat Lay Lee, Alex Lafever, Elizaveta A. Svyatova, Kevin Kanda, Amber L. Collier, Lauren L. Siewertsz van Reesema, Angela M. Tang-Tan, Vasilena P. Zheleva et al. · 2018 · Cancers
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Carmelo Laface, Riccardo Memeo, Felicia Maria Maselli, Anna Natalizia Santoro, Maria Laura Iaia, Francesca Ambrogio, Marigia Laterza, Gerardo Cazzato, Chiara Guarini, Pierluigi De Santis et al. · 2023 · Life
Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity
Béatrice Zitti, Florent Duval, P. Wirapati, Mehdi Hicham, Yuxuan Xie, Juhyun Oh, Jan Hoelzl, Philippa Meiser, Marco Varrone, Hannah M. Peterson et al. · 2025 · Immunity
Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors
Besan H. Al-Saafeen, Bassam R. Ali, Eyad Elkord · 2025 · Frontiers in Immunology
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer
Adam L. Burrack, Zoe C. Schmiechen, Michael T. Patterson, Ebony A. Miller, Ellen J. Spartz, Meagan R. Rollins, Jackson F. Raynor, Jason S. Mitchell, Tsuneyasu Kaisho, Brian T. Fife et al. · 2022 · JCI Insight
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
Marc Pfefferlé, Irina L. Dubach, Raphael M. Buzzi, Elena Duerst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy et al. · 2023 · Journal for ImmunoTherapy of Cancer
Nano-adjuvants and immune agonists promote antitumor immunity of peptide amphiphiles
Huan Yan, Guibin Lin, Zhanyan Liu, Fei Gu, Yuan Zhang · 2023 · Acta Biomaterialia
Multiomics Empowers Predictive Pancreatic Cancer Immunotherapy
Janelle Marie Montagne, Elizabeth M. Jaffee, Elana Judith Fertig · 2023 · The Journal of Immunology
Macrophage regulation of B cell proliferation
N. Goldman, Kornelija Valiuskyte, Jennifer Londregan, Adam Swider, J. Somerville, J. Riggs · 2017 · Cellular Immunology
Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance
Irina Krykbaeva, Kate Bridges, William Damsky, Gabriela A. Pizzurro, Amanda F. Alexander, Meaghan K. McGeary, Koonam Park, Viswanathan Muthusamy, Jim E. Eyles, Nadia Luheshi et al. · 2023 · Cancer Immunology Research
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
Peter J. Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P. Neoptolemos · 2023 · Function
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Christo Kole, Nikolaos Charalampakis, Sergios A. Tsakatikas, Maximos Frountzas, Konstantinos G Apostolou, Dimitriοs Schizas · 2022 · Dove Medical Press (Taylor and Francis Group)
Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: Beyond EPR effect
Mayu Yamamoto, Taiki Kurino, Reiko Matsuda, Haleigh Sakura Jones, Yoshito Nakamura, Taisei Kanamori, Atushi B. Tsuji, Aya Sugyo, Ryota Tsuda, Yui Matsumoto et al. · 2022 · Journal of Controlled Release
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
Jeffrey L. Wong, Patrick Smith, Juan Carlos Angulo-Lozano, Daniel L Ranti, Bernard H. Bochner, John P. Sfakianos, Amir Horowitz, Jeffrey V. Ravetch, David A. Knorr · 2023 · Proceedings of the National Academy of Sciences
Human dendritic cell subsets in the glioblastoma-associated microenvironment
Xiaopeng Hu, Chunmei Jiang, Yang Gao, Xingkui Xue · 2023 · Journal of Neuroimmunology
Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance
Filip Bednar, Marina Pasca di Magliano · 2020 · Cancer Cell
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
Saber Amin, Michael J. Baine, Jane L. Meza, Morshed Alam, Chi H. Lin · 2020 · Radiation Oncology
Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought
Antonio Agostini, Arturo Orlacchio, Carmine Carbone, Ilaria Guerriero · 2022 · Frontiers in Immunology
Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis
Ruining Gong, Ying Chen, David Kuang-Fu Chang, Huan Zhang, Zimin Liu, Qian Yu · 2025 · Frontiers in Immunology
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
Saber Amin, Michael J. Baine, Jane L. Meza, Chi H. Lin · 2020 · BMC Cancer
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos G Apostolou, Dimitrios Schizas · 2022 · Cancer Management and Research
Brief exposure of skin to near‐infrared laser augments early vaccine responses
Shinya Yokomizo, Wataru Katagiri, Yohei Maki, Tomoya Sano, Kazumasa Inoue, Masahiro Fukushi, Dmitriy N. Atochin, Toshihiro Kushibiki, Akihiko Kawana, Yoshifumi Kimizuka et al. · 2021 · Nanophotonics
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi · 2024 · Cancers
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, Frank Tacke, Linda Hammerich · 2024 · Seminars in Liver Disease
Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
Songyu Guo, Zhenxia Wang · 2024 · Frontiers in Oncology
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, Cheng Qin, Lin Chen, Zeru Li, Bangbo Zhao, Tianyu Li, Xiangyu Zhang, Weibin Wang · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Current and Evolving Therapies for Metastatic Pancreatic Cancer: Are We Stuck With Cytotoxic Chemotherapy?
Gauri Rajani Varadhachary, Robert A. Wolff · 2016 · Journal of Oncology Practice
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor
Saber Amin, Michael J. Baine, Jane L. Meza, Morshed Alam, Chi H. Lin · 2020 · Clinical and Translational Radiation Oncology
The Achilles’ Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials
Despina Siolas, C. Morrissey, Paul E. Oberstein · 2020 · Journal of Pancreatology
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas
Chang Su, Soo Kyoung Kim, Charles X. Wang, David G. Kirsch, Arta Monir Monjazeb · 2024 · Seminars in Radiation Oncology
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Ceire A. Hay, Rina Sor, Ahron J. Flowers, Cynthia J. Clendenin, Katelyn T. Byrne · 2019 · Journal of Visualized Experiments
Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis
Ce Li, Zhenzi Peng, Yizhou Wang, Gloria Lam, Nicholas N. Nissen, Jie Tang, Xiaopu Yuan, Michael S. Lewis, Mark Irwin Greene, Stephen Jacob Pandol et al. · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy
Meredith L. Stone, Jesse Lee, Veronica M. Herrera, Kathleen L. Graham, Jae Woo Lee, Austin P. Huffman, Heather Coho, Evan Tooker, Max I. Myers, Michael A. Giannone et al. · 2021 · JCI Insight
Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment
Takashi Watanabe · 2021 · Cancers
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
Yuanshuai Su, Xinyu Gu, Qiuxian Zheng, Lingxiao Zhu, Juan Lü, Lanjuan Li · 2022 · Frontiers in Oncology
Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer
James Wang, Brett Z. Fite, Aris J. Kare, Bo Wu, Marina Nura Raie, Spencer K. Tumbale, Nisi Zhang, Ryan R. Davis, Clifford G. Tepper, Sharon Aviran et al. · 2022 · Theranostics
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
Chris T.P. Do, Jack Yancy Prochnau, A. Mediero Domínguez, Pei Wang, Manjeet K. Rao · 2024 · Biomedicines
Age-Related Changes on CD40 Promotor Methylation and Immune Gene Expressions in Thymus of Chicken
Yulong Li, Xinyu Lei, Hong Lü, Wei Guo, Shengru Wu, Zhenchen Yin, Qingzhu Sun, Xiaojun Yang · 2018 · Frontiers in Immunology
Pancreatic ductal adenocarcinoma holds unique features to form an immunosuppressive microenvironment: a narrative review
Qiang Zhou, Dan Chen, Junfeng Zhang, Ji-Feng Xiang, Tao Zhang, Huaizhi Wang, Yanyan Zhang · 2022 · Journal of Pancreatology
The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma
Maria Diab, Bassel F. El‐Rayes · 2022 · Journal of Cancer Metastasis and Treatment
Combining Radiation with Immunotherapy: The University of Pennsylvania Experience
Leo Y. Luo, Mark H. O’Hara, Tara C. Mitchell, Robert H. Vonderheide, E. John Wherry, Andy J. Minn, Amit M. Maity · 2020 · Seminars in Radiation Oncology
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert, Peter Mirtschink, Anna Klimová, Florian Bösch, Torsten Tonn, Jochen Gaedcke et al. · 2023 · npj Precision Oncology
The emerging role of co-stimulatory molecules and their agonistic mAb-based combination therapies in melanoma
Shan He, Jinhua Xu, Jinfeng Wu · 2020 · International Immunopharmacology
Uncovering key targets of success for immunotherapy in pancreatic cancer
Andrea Pretta, Eleonora Lai, Mara Persano, Clelia Donisi, Giovanna Pinna, Erika Cimbro, Alissa Parrino, Dario Spanu, Stefano Mariani, Nicole Liscia et al. · 2021 · Expert Opinion on Therapeutic Targets
Novel and emerging innate immune therapeutic targets for pancreatic cancer
Liang Wang, Imad Shureiqi, John R. Stroehlein, Daoyan Wei · 2018 · Expert Opinion on Therapeutic Targets
The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
Saber Amin, Michael J. Baine, Jane L. Meza, Chi H. Lin · 2020 · Frontiers in Oncology
A prognostic model for anoikis-related genes in pancreatic cancer
Wenbin Song, Haiyang Hu, Zhengbo Yuan, Hao Yao · 2024 · Scientific Reports
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
Emily S. Clark, Ana Paula Benaduce, Wasif Noor Khan, Olivier Martínez, Eli Gilboa · 2024 · Cancer Immunology Immunotherapy
Report on the Third FDA–AACR Oncology Dose-Finding Workshop
Leisha A. Emens, René Bruno, Eric H. Rubin, Elizabeth M. Jaffee, Amy E. McKee · 2017 · Cancer Immunology Research
The Association of Immunotherapy With the Overall Survival of Inoperable Stage III Non-small Cell Lung Cancer Patients Who Do Not Receive Chemoradiation
Saber Amin, Michael J. Baine, I. Abdul Rahman, Chi H. Lin · 2022 · Journal of Immunotherapy
Single Treatment Boiling Histotripsy Focused Ultrasound Ablation Neither Negates nor Enhances the Activity of α-CD40 in a Pancreatic Cancer Model
Mariia Stepanechko, Awndre Gamache, Frederic R. Padilla, Madison Nemshick, Lydia E. Kitelinger, Claire A Conarroe, Matthew R. DeWitt, John A. Hossack, Timothy N. J. Bullock · 2025 · IEEE Transactions on Biomedical Engineering
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
Sara Labiano, Javier Marco-Sanz, Iker Ausejo‐Mauleon, Virginia Laspidea, Reyes Hernández-Osuna, Marc García-Moure, Daniel de la Nava, Sara Nuin, Marisol González-Huarriz, Timothy N. Phoenix et al. · 2025 · Cell Reports Medicine
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
Thomas Enzler, Anna Nguyen, Jamal Ghazi Misleh, Vivian Jean M. Cline, M. Johns, Nathan M. Shumway, Steven Paulson, R. Siegel, Timothy G. Larson, Wells A. Messersmith et al. · 2024 · European Journal of Cancer
Advances in improving the efficacy of anti-PD-1/PD-L1 therapy in intrahepatic cholangiocarcinoma
Shanhe Huang, Chenguang Hua, Bo Ding, Junru Chen, Shusen Zheng, Chaofeng Ding · 2025 · Critical Reviews in Oncology/Hematology
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma
Ri-Lan Bai, Nan-Ya Wang, Lingling Zhao, Yong‐Fei Zhang, Jiuwei Cui · 2021 · Hepatobiliary & pancreatic diseases international
Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
Jiabin Yang, Liangtang Zeng, Ruiwan Chen, Leyi Huang, Zhuo Kui Wu, Min Yu, Yu Zhou, Rufu Chen · 2023 · Cancers